The Genentech division of Roche said that Bill Anderson, who has been with the company for a decade, will replace Ian Clark as CEO. Anderson has been running North American commercial operations, the company said. He joined South San Francisco, CA-based Genentech in 2006 from Biogen, where he held a top spot in the neurology business. The changeover takes place January 1.
Author: Alex Lash
I've spent nearly all my working life as a journalist. I covered the rise and fall of the dot-com era in the second half of the 1990s, then switched to life sciences in the new millennium. I've written about the strategy, financing and scientific breakthroughs of biotech for The Deal, Elsevier's Start-Up, In Vivo and The Pink Sheet, and Xconomy.
View all posts by Alex Lash
